Is Avanos Medical, Inc. (AVNS) a Buy, Sell, or Hold?
Avanos Medical, Inc.
NYSE:AVNS
$24.93 USD
$0 (0.0%)
- Volume
- 357.27K
- Average Volume
- 1.67M
- Market Capitalization
- $1.17B
- P/E Ratio
- -16.61
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $25.49
- Year Low
- $9.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.48
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | David C. Pacitti |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | AVNS |
| CUSIP | 05350V106 |
| CIK | 0001606498 |
| Web | https://avanos.com |
| Phone | 844 428 2667 |
| Currency | USD |
| Employees | 2287 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.18 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.48 |
| Quick Ratio | 1.40 |
| Cash Ratio | 0.50 |
Sales & Book Value
| Annual Sales | $701.2M |
| Price / Sales | 1.63 |
| Cash Flow | 0.16 |
| Price / Cash Flow | 155.72 |
| Price / Book | 1.48 |
Price Target and Rating
| Average Stock Price Forecast | $23.00 |
| High Stock Price Forecast | $26.00 |
| Low Stock Price Forecast | $20.00 |
| Forecast Upside/Downside | 8.39% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 8 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-1.46 |
| Trailing P/E Ratio | -16.61 |
| PEG Ratio | -0.39 |
| P/E Growth | -0.39 |
| Net Income | $-67.9M |
| Net Margin | -9.69% |
| Pretax Margin | -9.54% |
| Return on Equity | -8.91% |
| Return on Assets | -6.61% |
Financials Score
| AltmanZ Score | 2.29 |
| Piotroski Score | 4.00 |
| Working Capital | 193.8M |
| Total Assets | 1.05B |
| Ebit | -61.1M |
| Market Cap | 1.17B |
| Total Liabilities | 268M |
Poll Results
About Avanos Medical, Inc. (NYSE:AVNS) Stock
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solu ... tions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
2026-07-02 10:00:00
ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
2026-06-25 14:00:00
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026
2026-06-24 15:00:00
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
2026-06-24 14:54:00
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
2026-06-24 10:50:41
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
2026-06-12 11:47:00
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
2026-06-11 16:16:49
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
2026-06-04 12:31:18
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Frequently Asked Questions
-
What is the current Avanos Medical, Inc. (AVNS) stock price?
-
Avanos Medical, Inc.(NYSE:AVNS) stock price is $24.93 in the last trading session. During the trading session, AVNS stock reached the peak price of $25.49 while $9.303 was the lowest point it dropped to. The percentage change in AVNS stock occurred in the recent session was 0.0% while the dollar amount for the price change in AVNS stock was $0.
-
AVNS's industry and sector of operation?
-
The NYSE listed AVNS is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of AVNS?
-
Sigfrido Delgado | Senior Vice President of Operations
David C. Pacitti | Chief Executive Officer & Director
Jason Pickett | Vice President of Corporate Finance & Treasurer
John Joseph Hurley | Principal Accounting Officer & Controller
John S. Fischer | Vice President, Head of Legal & Secretary -
How many employees does AVNS have?
-
Number of AVNS employees currently stands at 2287. AVNS operates from 5405 Windward Parkway, Alpharetta, GA 30004, US.
-
Link for AVNS official website?
-
Official Website of AVNS is: https://avanos.com
-
How do I contact AVNS?
-
AVNS could be contacted at phone #844 428 2667 and can also be accessed through its website. AVNS operates from 5405 Windward Parkway, Alpharetta, GA 30004, US.
-
How many shares of AVNS are traded daily?
-
The average number of AVNS shares traded daily for last 3 months was 1.67M.
-
What is the market cap of AVNS currently?
-
The market value of AVNS currently stands at $1.17B with its latest stock price at $24.93